PRESS RELEASE published on 09/13/2023 at 07:00, 2 years 8 months ago Evolva and Nice & Green agree on improvements to financing agreement
PRESS RELEASE published on 09/06/2023 at 07:00, 2 years 8 months ago Evolva receives approval for Veri-teTM Resveratrol in Thailand
PRESS RELEASE published on 08/24/2023 at 20:00, 2 years 8 months ago Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
PRESS RELEASE published on 08/24/2023 at 07:00, 2 years 8 months ago Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges
PRESS RELEASE published on 07/28/2023 at 07:00, 2 years 9 months ago Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year
PRESS RELEASE published on 07/25/2023 at 07:00, 2 years 9 months ago Evolva receives approval for Veri-teTM Resveratrol in Taiwan
PRESS RELEASE published on 06/26/2023 at 07:00, 2 years 10 months ago Evolva Holding SA: Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives
PRESS RELEASE published on 06/14/2023 at 07:00, 2 years 11 months ago Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance
PRESS RELEASE published on 05/05/2023 at 07:00, 3 years ago Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026
PRESS RELEASE published on 04/24/2023 at 07:00, 3 years ago Evolva publishes timeline of the Reverse Stock Split
Published on 05/23/2026 at 00:15, 25 minutes ago Molten Metals Completes Airborne Geophysical Survey at Texas Project
Published on 05/23/2026 at 00:00, 40 minutes ago Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
Published on 05/22/2026 at 14:04, 10 hours 36 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 22:05, 2 hours 35 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 2 hours 35 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 4 hours 48 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 6 hours 7 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 6 hours 9 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 5 hours 5 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 6 hours 34 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 6 hours 34 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 11 hours 47 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 11 hours 47 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
